Further Evidence of Severe Allergic Contact Dermatitis From Isobornyl Acrylate While Using a Continuous Glucose Monitoring System

J Diabetes Sci Technol. 2018 May;12(3):630-633. doi: 10.1177/1932296818762946. Epub 2018 Mar 15.


In the past decade, new diabetes technologies, including continuous glucose monitoring (CGM) systems, support patients with diabetes in their daily struggle with achieving a good glucose control. However, shortly after the first CGM systems appeared on the market, also the first concerns about adverse skin reactions were raised. Most patients claimed to suffer from (sometimes severe) skin irritation, or even allergy, which they related to the (acrylate-based) adhesive part of the device. For a long time the actual substance that caused these skin reactions with, for example, the Flash Glucose Monitoring system (iscCGM; Freestyle® Libre) could not be identified; however, recently Belgian and Swedish dermatologists reported that the majority of their patients that have developed a contact-allergic while using iscCGM react sensitively to a specific acrylate, that is, isobornyl acrylate (IBOA). Subsequently they showed by means of gas chromatography-mass spectrometry that this substance is present in the case of the glucose sensor attached by an adhesive to the skin. We report three additional cases from Germany, including a 10-year-old boy, suffering from severe allergic contact dermatitis to IBOA.

Keywords: FGM; acrylates; adhesives; allergic contact dermatitis; contact allergy; continuous glucose monitoring; flash glucose monitoring; insulin pump; isobornyl acrylate; medical device; patch pump; patch test.

Publication types

  • Case Reports

MeSH terms

  • Acrylates / adverse effects*
  • Adhesives / adverse effects*
  • Blood Glucose Self-Monitoring / instrumentation*
  • Camphanes / adverse effects*
  • Child
  • Dermatitis, Allergic Contact / etiology*
  • Diabetes Mellitus, Type 1
  • Humans
  • Male


  • Acrylates
  • Adhesives
  • Camphanes
  • isobornyl acrylate